One Disadvantage Is Prolonged Duration of Action
When it comes to intubating patients who are at least 80 years of age, a 0.9-mg/kg dose of rocuronium results in shorter onset times than a 0.3-mg/kg dose of the neuromuscular blocking agent, according to the results of a new Danish study. The authors were quick to add, however, that the larger rocuronium dose also resulted in a longer duration of action.
“A number of drugs may act differently in older people,” said Lars S. Rasmussen,